# Comparing ARNI With ACE Inhibitor on Endothelial Function

> **NCT03119623** · PHASE4 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** sacubitril/valsartan
- **DRUG:** Enalapril

## Key facts

- **NCT ID:** NCT03119623
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06-01
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lost funding prior to study commencing
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119623, "Comparing ARNI With ACE Inhibitor on Endothelial Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03119623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*